Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hod

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|February 1, 1991
Prognostic importance of delayed Q-wave evolution 3 to 24 hours after initiation of thrombolytic therapy for acute myocardial infarctionM J Eisenberg, G I Barbash, H Hod, et al.
The American Journal of Cardiology|July 15, 1989
Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarctionG I Barbash, H Hod, S Rath, et al.
Journal of the American College of Cardiology|April 1, 1990
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot studyA Roth, G I Barbash, H Hod, et al.
British Heart Journal|October 1, 1990
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial InfarctionG I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology|December 1, 1989
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarctionG I Barbash, H Hod, A Roth, et al.
American Journal of Rhinology & Allergy|March 22, 2021
Simulation of Cerebrospinal Fluid Leak Repair Using a 3-Dimensional Printed ModelMuhamed A Masalha, Kyle K VanKoevering, Omar S Latif, et al.
The American Journal of Cardiology|September 1, 1990
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology|August 1, 1990
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.
Journal of the American College of Cardiology|October 1, 1990
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemiaG I Barbash, H Hod, A Roth, et al.
The American Journal of Cardiology|October 29, 2000
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarctionM S Feinberg, E Schwammenthal, L Shlizerman, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|February 1, 1991
Prognostic importance of delayed Q-wave evolution 3 to 24 hours after initiation of thrombolytic therapy for acute myocardial infarctionM J Eisenberg, G I Barbash, H Hod, et al.
The American Journal of Cardiology|July 15, 1989
Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarctionG I Barbash, H Hod, S Rath, et al.
Journal of the American College of Cardiology|April 1, 1990
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot studyA Roth, G I Barbash, H Hod, et al.
British Heart Journal|October 1, 1990
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial InfarctionG I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology|December 1, 1989
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarctionG I Barbash, H Hod, A Roth, et al.
American Journal of Rhinology & Allergy|March 22, 2021
Simulation of Cerebrospinal Fluid Leak Repair Using a 3-Dimensional Printed ModelMuhamed A Masalha, Kyle K VanKoevering, Omar S Latif, et al.
The American Journal of Cardiology|September 1, 1990
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology|August 1, 1990
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.
Journal of the American College of Cardiology|October 1, 1990
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemiaG I Barbash, H Hod, A Roth, et al.
The American Journal of Cardiology|October 29, 2000
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarctionM S Feinberg, E Schwammenthal, L Shlizerman, et al.
Pageof 11